NCT01606280

Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation

Reporting of Amyloidosis Stem Cell Transplantation Outcomes

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 400 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study examines the value of stem cell transplantation in managing light chain amyloidisis.

Detailed description

1. How does age at diagnosis affect prognosis in primary amyloidosis? 2. How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis? 3. How does degree of organ involvement/number of organs involved affect prognosis in primary amyloidosis? 4. How does initial treatment affect prognosis in primary amyloidosis? 4\. How do the specifics the stem cell transplant protocol affect prognosis in primary amyloidosis?

Conditions

• Amyloidosis

Timeline

• Start date: 2011-06-01
• Primary completion: 2013-06-01
• Completion: 2013-06-01
• First posted: 2012-05-25
• Last updated: 2014-01-22

Locations

1 site across 1 country: United States